OKYO
OKYO Pharma Limited
NASDAQ · Healthcare · Biotechnology · GB
$1.57
+1.29%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-110.7%
Return on equity
-65.1%
Return on assets
-132.9%
Return on invested capital
0.00x
Asset turnover
-$7.7M
Cash from operations
$0.39
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026